Alongside biosimilars, Beneva has forged product listing agreements that offer a 12% average discount on more than 50 ...
TipRanks on MSN3d
iX Biopharma Unveils Growth Plans at AGMX Biopharma Ltd. (SG:42C) has released an update. iX Biopharma Ltd. recently held its Annual General Meeting where key ...
Cns Pharmaceuticals, Inc. ( (CNSP) ) has released its Q3 earnings. Here is a breakdown of the information Cns Pharmaceuticals, Inc. presented ...
The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...
Leerink Partners analyst Mani Foroohar maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report) on November 12 and set a ...
“FDA has not yet developed action plans to fully address travel, workload, and work-life balance because potential solutions ...
BP p.l.c.'s recent management changes and strategic moves, including the Travel Centers of ... when combined with an action ...
The stock commands a market value of Rs 95477.64 crore and is part of the Pharma - Indian industry. The scrip has been an ...
"It is clear we need to fundamentally change our strategy to win back customers and return to growth. Back to Starbucks is that fundamental change," Niccol said. "We have to get back to what has ...
It’s not clear whether this new plan would require the firm to pay more.) Early reactions from the pharmaceutical industry suggest it’s not thrilled. On Saturday morning, David Reddy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback